137 related articles for article (PubMed ID: 37315888)
1. OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma.
Yang T; Liang N; Zhang J; Bai Y; Li Y; Zhao Z; Chen L; Yang M; Huang Q; Hu P; Wang Q; Zhang H
Metabolism; 2023 Oct; 147():155628. PubMed ID: 37315888
[TBL] [Abstract][Full Text] [Related]
2. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.
Ji X; Yang Z; Li C; Zhu S; Zhang Y; Xue F; Sun S; Fu T; Ding C; Liu Y; Wan Q
Metabolism; 2024 Mar; 152():155761. PubMed ID: 38104924
[TBL] [Abstract][Full Text] [Related]
4. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.
Wu D; Yang Y; Hou Y; Zhao Z; Liang N; Yuan P; Yang T; Xing J; Li J
Cancer Commun (Lond); 2022 Jan; 42(1):37-55. PubMed ID: 34981667
[TBL] [Abstract][Full Text] [Related]
5. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
[TBL] [Abstract][Full Text] [Related]
6. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
7. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation.
Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL
J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219
[TBL] [Abstract][Full Text] [Related]
8. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling.
Ma APY; Yeung CLS; Tey SK; Mao X; Wong SWK; Ng TH; Ko FCF; Kwong EML; Tang AHN; Ng IO; Cai SH; Yun JP; Yam JWP
Cancer Res; 2021 Jul; 81(13):3679-3692. PubMed ID: 33975883
[TBL] [Abstract][Full Text] [Related]
10. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
11. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
13. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
14. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
[TBL] [Abstract][Full Text] [Related]
15. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate.
Grigat S; Fork C; Bach M; Golz S; Geerts A; Schömig E; Gründemann D
Drug Metab Dispos; 2009 Feb; 37(2):330-7. PubMed ID: 18981167
[TBL] [Abstract][Full Text] [Related]
16. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
18. STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma.
Zhao H; Yan G; Zheng L; Zhou Y; Sheng H; Wu L; Zhang Q; Lei J; Zhang J; Xin R; Jiang L; Zhang X; Chen Y; Wang J; Xu Y; Li D; Li Y
Theranostics; 2020; 10(14):6483-6499. PubMed ID: 32483465
[No Abstract] [Full Text] [Related]
19. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.
Dinarvand N; Karimi F; Azizi R; Rastaghi S; Sheikhi A; Pourfarzam M
Mol Biol Rep; 2023 Mar; 50(3):2061-2066. PubMed ID: 36539562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
